Company news
Celldex Therapeutics, Inc. news in 2019
Celldex Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Celldex Initiates Phase 1 Study of KIT Inhibitor CDX-0159
November 17, 2019
Celldex Provides Corporate Update and Reports Third Quarter 2019 Results
November 11, 2019
Celldex Presents Promising Data from CDX-0159 and CDX-527 Programs
November 10, 2019
CDX-1140 Demonstrates Clinical and Biological Activity in Patients with Advanced Solid Tumors in Phase 1 Dose Escalation Study
November 7, 2019
Celldex Therapeutics Announces Upcoming Data Presentations
October 1, 2019
Celldex Therapeutics to Present at the Cantor Global Healthcare Conference
September 29, 2019